scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0171-2985(96)80024-6 |
P698 | PubMed publication ID | 8933159 |
P2093 | author name string | H H Goebel | |
H Lassmann | |||
H A Kretzschmar | |||
M Bergmann | |||
W Brück | |||
U Zettl | |||
N Sommermeier | |||
P2860 | cites work | Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis | Q24297982 |
The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions | Q31170766 | ||
The role of macrophages in demyelination | Q35513547 | ||
Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: correlation with chronicity of the lesion | Q38490624 | ||
The significance of perivascular infiltrations in multiple sclerosis | Q39372080 | ||
The nature of inflammatory components during demyelination in multiple sclerosis | Q39545636 | ||
Acute demyelinating disease. Classification and non-invasive diagnosis | Q41101210 | ||
Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats | Q41348774 | ||
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages | Q42017099 | ||
Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases | Q44968700 | ||
Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions | Q48126443 | ||
Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis | Q48152702 | ||
Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue | Q48164017 | ||
Macrophage populations associated with multiple sclerosis plaques | Q48188922 | ||
Oligodendrocytes in the early course of multiple sclerosis | Q48196640 | ||
Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis | Q48215982 | ||
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions | Q48338419 | ||
Bone marrow derived elements and resident microglia in brain inflammation | Q48392493 | ||
Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues | Q48581313 | ||
Monocyte/macrophage differentiation in early multiple sclerosis lesions | Q48752790 | ||
Patterns of oligodendroglia pathology in multiple sclerosis | Q61709808 | ||
Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis | Q69788388 | ||
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains | Q71659583 | ||
Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro | Q72182699 | ||
Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization | Q72427037 | ||
Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats | Q72556738 | ||
A comparison of the pathology of primary and secondary progressive multiple sclerosis | Q72708285 | ||
P433 | issue | 4-5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 588-600 | |
P577 | publication date | 1996-10-01 | |
P1433 | published in | Immunobiology | Q15754985 |
P1476 | title | Macrophages in multiple sclerosis | |
P478 | volume | 195 |
Q26749307 | Albumin and multiple sclerosis |
Q42238962 | Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs |
Q77402602 | Apoptosis induction by macrophage-derived reactive oxygen species in myelin-specific T cells requires cell-cell contact |
Q37316406 | Beyond blood brain barrier breakdown - in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI. |
Q35788387 | CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. |
Q48257647 | Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. |
Q33905233 | Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. |
Q37573005 | Chronic viral infections of the central nervous system: Aspects specific to multiple sclerosis |
Q47120039 | Deletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity |
Q24642895 | Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach |
Q47280518 | Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors |
Q46473196 | Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis |
Q58570680 | Immune-cell crosstalk in multiple sclerosis |
Q33613681 | Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies |
Q48589403 | Interferon-beta directly influences monocyte infiltration into the central nervous system. |
Q92266717 | Macrophages at CNS interfaces: ontogeny and function in health and disease |
Q37301528 | Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype |
Q42109077 | Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis. |
Q89957844 | Metabolic characterisation of THP-1 macrophage polarisation using LC-MS-based metabolite profiling |
Q37033330 | Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease |
Q39420793 | Multiple Sclerosis: Immunopathology and Treatment Update |
Q39388337 | Myeloid Cells in the Central Nervous System |
Q92724043 | Nanomodulation of Macrophages in Multiple Sclerosis |
Q33574527 | Phagocytosis of microglia in the central nervous system diseases |
Q52145132 | Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses. |
Q36854602 | Solitary Langerhans cell histiocytosis lesion of the parieto-occipital lobe: a case report and review of the literature |
Q39559510 | Soluble vascular endothelial growth factor (VEGF) receptor-1 inhibits migration of human monocytic THP-1 cells in response to VEGF. |
Q35825040 | Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. |
Q38007464 | The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids |
Q26765937 | The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach |
Q33699357 | The pathology of multiple sclerosis: a historical perspective |
Q34468304 | The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. |
Q44219240 | VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. |
Search more.